Replies to post #13020 on Seelos Therapeutics Inc (SEEL)

[Dimitrios George]

"My only point is that if they are working with the FDA, let somebody know about it other than us shareholders."

It just doesn't work that way. That would be a sure way to irritate the FDA.

The subject of your post is using FDA approved clinical procedures in an off label indication. He is not selling a drug.